M. A. Rossing

M. A. Rossing is a cancer epidemiology researcher at the German Cancer Research Center (DKFZ) in Heidelberg, Germany, with significant contributions to ovarian and breast cancer research. As evidenced by 56 publications in the DKFZ database, Dr. Rossing is an active researcher with extensive collaborations through the Ovarian Cancer Association Consortium (OCAC) and other international research networks.

Dr. Rossing's research focuses on understanding the genetic and epidemiological factors influencing ovarian and breast cancer risk and outcomes. Their work spans multiple areas including genome-wide association studies, polygenic risk modeling, biomarker development, and investigation of reproductive risk factors. Recent publications demonstrate expertise in molecular subtyping of ovarian cancer and the development of clinically applicable risk prediction tools.

The publication record shows a consistent output of high-impact research in leading oncology and genetics journals including Nature Communications, Journal of Clinical Oncology, American Journal of Human Genetics, and JAMA Oncology. The research demonstrates a strong emphasis on translating genetic findings into clinically relevant risk assessment tools.

• Extensive work on ovarian cancer genetic susceptibility
• Development of polygenic risk models for cancer prediction
• Investigation of reproductive factors in cancer etiology
• Analysis of molecular subtypes and their prognostic value

Dr. Rossing's collaborative approach is evident through authorship on numerous multi-institutional studies involving researchers from North America, Europe, and beyond. This collaborative network enables the large-scale analyses necessary for meaningful discoveries in cancer epidemiology.